Please login to the form below

Not currently logged in
Email:
Password:

market research

This page shows the latest market research news and features for those working in and with pharma, biotech and healthcare.

Communiqué Awards 2019 accepting entries

Communiqué Awards 2019 accepting entries

Here is the full list of categories available:. Excellence in Communication of Survey or Market Research Data.

Latest news

  • FDA clears first-line use for J&J’s myeloma drug Darzalex FDA clears first-line use for J&J’s myeloma drug Darzalex

    Market research firm Persistence reckons Darzalex and another therapeutic antibody – Roche’s Empliciti (elotuzumab) – which “will not only provide a new treatment option for multiple myeloma patients, but they will also

  • Novartis and Pfizer to collaborate on NASH combinations Novartis and Pfizer to collaborate on NASH combinations

    and an untapped pharma market as there are as yet no approved treatments. ... Market analysts Research and Markets has forecast the NASH market will reach a very sizeable $20.68 billion by 2025, once the first competitors gain approval. .

  • Artificial intelligence in healthcare Artificial intelligence in healthcare

    With the cost of bringing a new drug to market now approaching $2bn – mainly due to a high attrition rate – anything that can improve the efficiency of R&D is being ... Recent market research from Global Market Insights (GMI) suggests that from a

  • Clinical trial ‘High Throughput Centres’ could help UK compete post-Brexit Clinical trial ‘High Throughput Centres’ could help UK compete post-Brexit

    in the country, and help it compete in the global clinical research market post-Brexit. ... Read the IAOCR white paper here: High Throughput Clinical Research Centres in the NHS: A report to the UK Government from the clinical research sector..

  • Checkpoint inhibitor scientists win Nobel Prize Checkpoint inhibitor scientists win Nobel Prize

    at the heart of research into CTLA4 which led to the development of inhibitors such as BMS’ Yervoy (ipilimumab) and various late-stage clinical candidates. ... With new drugs targeting the PD-1 and CTLA4 pathways no reaching the market – and

More from news
Approximately 11 fully matching, plus 360 partially matching documents found.

Latest Intelligence

  • Escaping the spin cycle of sub-optimal launch Escaping the spin cycle of sub-optimal launch

    However, articulating one isn’t easy. “Organisations are swimming in market complexity and research covering the full spectrum of the science and the healthcare ecosystem,” says Peter Smith. ... Finally, marketers must be brave enough to deny the

  • Launch like a PRO: the art and science of successful entry to market Launch like a PRO: the art and science of successful entry to market

    From strategy to project management, market access to public affairs, governance to HEOR, they provide an incredibly thorough test of an organisation’s capability. ... The methodology is simple but powerful. Rigorous desk and customer research into the

  • Brand teams: why are some smarter than others? Brand teams: why are some smarter than others?

    Compared to your rivals, you and your colleagues have similar backgrounds, use similar methods and work with more or less the same data bought from the same market research companies. ... My research has uncovered that there are two complementary

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    As biosimilars surge into the insulin market, governments  are urged to seize ‘the opportunity of the century’. ... The need for new drugs follows that trajectory with a report from analysts Research and Markets predicting the insulin market will

  • Digging deeper to connect with the powerful force of patient understanding Digging deeper to connect with the powerful force of patient understanding

    Market research is moving to a greater emphasis on quality of life; this is what the future is all about,” he says. ... Trautmann adds: “Pharma-ceutical development is a scientific process but market research needs to be consulted much earlier in the

More from intelligence
Approximately 13 fully matching, plus 64 partially matching documents found.

Latest appointments

  • New faces at BioStrata, P\S\L Group and FCB Health New faces at BioStrata, P\S\L Group and FCB Health

    Carolyn Chamberlain (below) has joined P S L Group as Managing Director, Instar Europe, the group’s global market research business. ... Chamberlain has over 20 years' experience in pharmaceutical market research, with a career beginning at AstraZeneca,

  • New faces at GCI Health, Porterhouse Medical and Research Partnership New faces at GCI Health, Porterhouse Medical and Research Partnership

    She has previous experience in market research in a communications and strategy consultancy. ... Meanwhile Emma Warburton joins the agency as business development executive after previously working as a pricing and market research analyst.

  • Pharma industry appointments Pharma industry appointments

    UK. Vu, whose new post will see him further expand Concept’s presence in the US market, joins the company with over 15 years’ experience in both business development and project ... He joins Concept from Eurofins, where he was director of business

  • Gamida Cell strengthens leadership team Gamida Cell strengthens leadership team

    Nee will lead market research, analytics, forecasting, commercial strategies and competitive intelligence at the company, activities he has practised during his time with Biogen, Amgen and Novartis.

  • STEM Healthcare bolsters its EU5 team STEM Healthcare bolsters its EU5 team

    Meanwhile, Joanna Troman (pictured left) moves to STEM as a project director following 10 years as Sanofi Pasteur MSD in a number of roles across marketing, strategic planning and market research.

More from appointments
Approximately 5 fully matching, plus 50 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 120 fully matching, plus 485 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics